Ranitidine and gastrointestinal bleeding in intensive careBMJ 2001; 322 doi: http://dx.doi.org/10.1136/bmj.322.7292.995/a (Published 21 April 2001) Cite this as: BMJ 2001;322:995
Should prophylaxis against stress ulcer be abandoned for patients in intensive care?
- Jean-Charles Preiser ([email protected]), clinical director
- Clinique Reine Fabiola, 73 avenue du Centenaire, B6061 Montignies-sur-Sambre, Belgium
- Wycombe Hospital, Wycombe HP11 2TT
EDITOR—The meta-analysis of Messori et al clearly confirms the lack of usefulness of systematic prophylaxis against stress ulcer with H2 receptor antagonists or sucralfate,1 but an important issue is left unanswered by this study and by the meta-analysis of Cook et al.2 Indeed, some critically ill patients receive prophylaxis against stress ulcers for specific reasons, including brain injury (trauma, surgery, haemorrhage), steroid treatment, and coagulation abnormalities.
Does the available literature support such prophylaxis for these patients? In other words, should intensivists prescribe stress ulcer prophylaxis for selected subgroups of patients? If the available literature does not resolve this issue, should the further trials suggested by Messori et …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial